Your Good Partner in Biology Research

Human prokineticin 1(PROK1/EG-VEGF) ELISA kit

  • 中文名称:
    人前动力蛋白1(PROK1/EG-VEGF)酶联免疫试剂盒
  • 货号:
    CSB-E04532h
  • 规格:
    96T/48T
  • 价格:
    ¥3200/¥2500
  • 其他:

产品详情

  • 产品描述:

    This Human PROK1 ELISA Kit was designed for the quantitative measurement of Human PROK1 protein in serum. It is a Sandwich ELISA kit, its detection range is 0.312 ng/mL-20 ng/mL and the sensitivity is 0.078 ng/mL.

  • 别名:
    Black mamba toxin related protein ELISA Kit; EG VEGF ELISA Kit; EG-VEGF ELISA Kit; EGVEGF ELISA Kit; Endocrine-gland-derived vascular endothelial growth factor ELISA Kit; Mambakine ELISA Kit; PK1 ELISA Kit; PRK1 ELISA Kit; PROK1 ELISA Kit; PROK1_HUMAN ELISA Kit; Prokineticin 1 ELISA Kit; Prokineticin-1 ELISA Kit
  • 缩写:
    PROK1
  • Uniprot No.:
  • 种属:
    Homo sapiens (Human)
  • 样本类型:
    serum
  • 检测范围:
    0.312 ng/mL-20 ng/mL
  • 灵敏度:
    0.078 ng/mL
  • 反应时间:
    1-5h
  • 样本体积:
    50-100ul
  • 检测波长:
    450 nm
  • 研究领域:
    Signal Transduction
  • 测定原理:
    quantitative
  • 测定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 线性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human EG-VEGF in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
      Sample Serum(n=4)
    1:1 Average % 103
    Range % 100-108
    1:2 Average % 95
    Range % 92-99
    1:4 Average % 88
    Range % 85-92
    1:8 Average % 99
    Range % 96-103
  • 回收率:
    The recovery of human EG-VEGF spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample Type Average % Recovery Range
    Serum (n=5) 102 100-105
  • 标准曲线:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/ml OD1 OD2 Average Corrected
    20 2.625 2.741 2.683 2.558
    10 2.268 2.166 2.217 2.092
    5 1.635 1.536 1.586 1.461
    2.5 1.053 1.044 1.049 0.924
    1.25 0.711 0.688 0.700 0.575
    0.625 0.430 0.436 0.433 0.308
    0.312 0.282 0.277 0.280 0.155
    0 0.121 0.129 0.125  
  • 数据处理:
  • 货期:
    3-5 working days

产品评价

靶点详情

  • 功能:
    Potently contracts gastrointestinal (GI) smooth muscle. Induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. Has little or no effect on a variety of other endothelial and non-endothelial cell types. Induces proliferation and differentiation, but not migration, of enteric neural crest cells. Directly influences neuroblastoma progression by promoting the proliferation and migration of neuroblastoma cells. Positively regulates PTGS2 expression and prostaglandin synthesis. May play a role in placentation. May play a role in normal and pathological testis angiogenesis.
  • 基因功能参考文献:
    1. PROK1 or MMP-2 in the amniotic fluid do not have a role in the prediction of adverse pregnancy outcomes. PMID: 29405963
    2. Elevated PROK1 in the first pregnancy trimester is a more effective marker than PAPP-A in the prediction of pre-eclampsia and fetal growth restriction. PMID: 28675948
    3. The VEGF/sVEGF-R1 ratio in follicular fluid on the day of oocyte retrieval in women undergoing IVF procedure, regardless of the type of stimulation protocol, might predict the risk of developing ovarian hyperstimulation syndrome (OHSS). To the best of our knowledge this is the first paper in the literature to show interplay among VEGF, EG-VEGF and sVEGF-R1 and the correlation between their concentration and OHSS risk. PMID: 28820403
    4. These findings demonstrate a novel function of primary cilia in controlling EG-VEGF-regulated trophoblast invasion and reveal the underlying molecular mechanism. PMID: 27736039
    5. miR-346 and miR-582-3p regulate EG-VEGF-induced trophoblast invasion through repressing MMP 2 and MMP 9, and may become novel diagnostic biomarkers or therapeutic targets for EG-VEGF-related obstetric disorders. (c) 2016 BioFactors, 43(2):210-219, 2017. PMID: 27619846
    6. Each follicular fluid (FF) was individually aspirated and FF/serum EG-VEGF, inhibin-a, and FF IGF-1 levels were evaluated. The pregnant group was characterized by increased numbers of WVFs (p = 0.044), a WVE (p = 0.022), and increased levels of FF IGF-1 (p = 0.001) and serum EG-VEGF (p = 0.03). PMID: 27484063
    7. Results show the biological effects of PROK1-V67I on cell functions are similar to those of wild type, and the common variant of V67I may act as a modifier in the PROK1-PROKR system through down-regulation of PROK1 expression. PMID: 26828479
    8. EG-VEGF and its receptor PKR1 might play a role in the pathogenesis of adrenocortical tumors and could serve as prognostic markers for this rare malignant disease. PMID: 26475302
    9. The prognosis was poorer in colorectal cancers that expressed both PROK1 and VEGF relative to the cases that expressed only 1 protein, and the expression of both proteins was found to be an independent prognostic factor. PMID: 26318037
    10. PROK1 levels in follicular fluid and fertilization culture media could constitute new predictive noninvasive markers of successful embryo implantation in conventional in vitro fertilization-embryo transfer PMID: 26401590
    11. Simultaneous targeting of both angiogenic growth factors (VEGF/PROK1) may prove more useful in colorectal cancer PMID: 25788276
    12. High Prokineticin 1 protein expression is associated with sporadic colorectal cancer. PMID: 25331005
    13. Expression of PROK1 and PROKR1 was significantly higher in mid-gestation ovaries (17-20 wk) than at earlier gestations (8-11 and 14-16 wk). PMID: 26192875
    14. More importantly this paper argues for EG-VEGF clinical relevance as a potential biomarker of the onset of pregnancy pathologies and discusses its potential usefulness for future therapeutic directions. PMID: 24955357
    15. EG-VEGF and VEGFA systems shared several canonical signaling pathways that may contribute to gene-gene interactions, including the Akt, IL-8, EGFR, MAPK, SRC, VHL, HIF-1A and STAT3. PMID: 24671265
    16. Study corroborates the clinical relevance of the EG-VEGF system in human early pregnancy, and provides evidence for the gene-gene interactions of EG-VEGF and PROKR variants. PMID: 25064403
    17. An increased mRNA expression of PROK1 and LIF could be one of the several abnormalities characterizing the endometrium in women recurrent pregnancy loss. PMID: 25128195
    18. Defective placental maturation is associated with an imbalance of expression of basic fibroblast growth factor (FGF) and PK1. PMID: 23891065
    19. preliminary data suggest a high potential of prokineticin 1 in the success of implantation and pregnancy PMID: 23972922
    20. number of blood vessels in PROK1-positive primary gastrointestinal lesions was higher than that in PROK1-negative primary lesions. CONCLUSION: PROK1 expression might be related to the extent of malignancy in gastrointestinal cancer PMID: 24324064
    21. EG-VEGF as a new placental growth factor acting during the first trimester of pregnancy, established its mechanism of action, and provide evidence for its deregulation in FGR. PMID: 22941044
    22. During the first trimester of pregnancy, hCG and EG-VEGF exhibit the same pattern of expression, suggesting that EG-VEGF is potentially regulated by hCG. PMID: 22138749
    23. Findings, together with the detection of sequence variants in PROKR1, PROK1 and PROKR2 genes associated to HSCR and, in some cases in combination with RET or GDNF mutations, provide evidence to consider them as susceptibility genes for HSCR. PMID: 21858136
    24. Data show that decidualization was associated with increased expression of 428 genes including SCARA5 (181-fold), DKK1 (71-fold) and PROK1 (32-fold), and decreased expression of 230 genes including MMP-7 (35-fold) and SFRP4 (21-fold). PMID: 21858178
    25. identified a novel signalling pathway whereby PROK1 can induce the expression of DKK1 in the human endometrium and first trimester decidua. PMID: 21546446
    26. The data shows that much more PK1 in healthy pregnant women is produced than those suffering from preeclampsia. PMID: 21876489
    27. Prok1 is significantly increased in ppapillary thyroid cancer, and its expression in PTC is related to BRAF mutation. PMID: 21385081
    28. CTGF expression in early pregnancy decidua is regulated by PROK1, via activation of the Gq, PLC, cSrc, EGFR, MAPK/ERK kinase pathway and has a role in cell adhesion. PMID: 21098624
    29. Data show that expression of PK1 and PKR1 was detected in primary MM cells and myeloma cell lines. PMID: 20795791
    30. When endometrial stromal cells from both groups of women were differentiated to decidual phenotype, PROK1 mRNA was up-regulated and PR and HOXA10 mRNA were down-regulated to the same extent. PMID: 20400074
    31. findings identify EG-VEGF as a novel paracrine regulator of trophoblast invasion. We speculate that a failure to correctly down-regulate placental expression of EG-VEGF at the end of the first trimester of pregnancy might lead to PE PMID: 19602057
    32. Altered expression of PROK1 could be one of the several biochemical abnormalities characterizing eutopic endometrium in endometriosis. PMID: 19285664
    33. Treatment of human decidua with a lentiviral miRNA to abolish endogenous PROK1 expression results in a significant reduction in IL-11 expression and secretion PMID: 19801577
    34. EG-VEGF expression was significantly higher in ectopic endometriotic tissue when compared to eutopic samples in infertile women. PMID: 19135668
    35. The role of EG-VEGF in the regulation of angiogenesis in endocrine glands. Review. PMID: 12858543
    36. acting via either PK-R2 or PK-R1, prokineticin 1 may have angiogenic as well as nonangiogenic functions in the ovary PMID: 12915658
    37. Expression of VEGFR-1 mRNA, but not EG-VEGF and the other three VEGF receptors studied, was elevated in preeclamptic vs. normal placentas. PMID: 15126581
    38. Human EG-VEGF may play a role in angiogenesis both during the early endocrine development of testis and in the adult testis as well as in Leydig cell tumor growth. PMID: 15292351
    39. EG-VEGF may only play a role in vascular function of peri-implantation endometrium, but is unlikely to be associated with the etiology of endometrial cancer development. PMID: 16210375
    40. PK1 could be one of the causative factors of age-related macular degeneration (AMD); transgenic mice expressing human PK1 exhibit choroidal neovascularization in a model that may be useful for establishing treatments for the exudative form of AMD. PMID: 16263331
    41. Inverse resgulation of mRNA expression by ovarian cells may suggest that in addition to its angiogenic effects, EG-VEGF/PK-1 may also play other roles in ovary. (review) PMID: 16320832
    42. High EG-VEGF is associated with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma PMID: 17167981
    43. Overexpressed Prk1 conferred Adriamycin resistance in a human embryo kidney cell line. PMID: 17178891
    44. EG-VEGF/Prok-1 signaling has a role in neuroblastoma progression PMID: 17289879
    45. Either EG-VEGF is not exclusive of endocrine organs, or the pancreas should be considered as a functional steroidogenic tissue. PMID: 17683928
    46. PROK1 and PROKR1 expression is elevated in human decidua during early pregnancy PROK1-PROKR1 interaction regulates expression of a host of implantation-related genes. PMID: 18339712
    47. EG-VEGF may enhance cell proliferation through the activation of MAPK pathway, although not through the Akt pathway. PMID: 18571163
    48. High PK1 mRNA levels were observed only in cultured pancreatic stellate cells and microdissected islet cells, but not in cancer cells, and PK1 protein was localized mainly in islets and cancer-associated stromal cells. PMID: 19077468
    49. hCG-mediated LIF expression in the endometrium is dependent on prior induction of PROK1. PMID: 19255255
    50. EG-VEGF protects pancreatic cancer cells from apoptosis through upregulation of myeloid cell leukemia-1, an anti-apoptotic protein of the bcl-2 family. PMID: 19523441

    显示更多

    收起更多

  • 亚细胞定位:
    Secreted.
  • 蛋白家族:
    AVIT (prokineticin) family
  • 组织特异性:
    Localizes to glandular epithelium, stroma and vascular epithelial cells of first trimester decidua (at protein level). Up-regulated in first trimester decidua when compared with non-pregnant endometrium. Expressed in the steroidogenic glands, ovary, testi
  • 数据库链接:

    HGNC: 18454

    OMIM: 606233

    KEGG: hsa:84432

    STRING: 9606.ENSP00000271331

    UniGene: Hs.514793